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Background. Genetic conditions and susceptibilities differ from other diseases and 
health-related risks. Genetic information is shared between blood relatives, and therefore 
a genetic finding can have implications for the wider family. 
Objective. The present study investigates people’s views on issues related to disclos-
ing genetic information to relatives. Specifically, the study assesses opinions in relation 
to two issues: 1) whether people have a moral obligation to share their genetic data with 
family members; and 2) whether healthcare providers should have a legal obligation to 
share such data when consent is withheld. 
Design. A public engagement event was held based on the real-life court case of 
ABC vs the UK National Health Service (NHS). Participants were provided with informa-
tion in three phases: first, about the case; then, with progressively more details of the case; 
and finally, with other relevant information. After being given each portion of informa-
tion, the participants were asked to disclose their views on the rights and responsibilities 
related to the sharing of this information.
Results. The results clearly demonstrate that people hold strong and polarized views 
regarding confidentiality, and the moral and legal duties to disclose genetic information 
to family members. Even when withholding information could have an adverse impact 
on the health and life choices of relatives, participants disagreed about the legal obliga-
tions for healthcare providers to disclose a person’s genetic information to those relatives. 
Conclusion. The results suggest that the issues of privacy and disclosure of genetic 
information are complex and divisive.
Keywords:  Genetics, ethics, public engagement, patient confidentiality, duty of care, 
data access rights.
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Introduction
Advances in genetic research and technologies have led to genetic testing being 
adopted more routinely as part of healthcare treatment in many countries (Botkin 
et al., 2014). For example, in the UK, the Chief Medical Officer’s 2016 report “Gen-
eration Genome” focused on the increasing importance of genomics in healthcare 
treatment and management (Davies, 2017). Most medical conditions have complex 
genetic etiologies in that they are influenced by many genetic factors (e.g. Balmain, 
Gray, & Ponder, 2003). However, some conditions follow relatively simple patterns 
of inheritance and expression.
Many countries have adopted new-born screening procedures to detect some 
of these conditions for early intervention and treatment. The number of disorders 
which are included in new-born screening varies in different countries, from two 
to more than 20 (Bodamer, Hoffmann, & Lindner, 2007; Kelly, Makarem, & Was-
serstein, 2016). In the UK, new-born screening is performed for disorders with rec-
ognizable latent or early symptomatic stages, and for which prevention programs 
or treatments are already available.
Based on these criteria, UK screening includes nine congenital disorders: sickle 
cell disease, cystic fibrosis, congenital hypothyroidism, phenylketonuria (PKU), 
medium-chain acylCoA dehydrogenase deficiency (MCADD), maple syrup urine 
disease (MSUD), isovaleric acidaemia (IVA), glutaric aciduria type 1 (GA1), and 
homocystinuria (pyridoxine unresponsive) (HCU) (NHS, 2018). There are many 
other single gene disorders for which molecular (genetic) diagnoses are available, 
but screening for them is not offered population-wide. This is due to the lack of an 
effective treatment (aside from symptom management) and the rarity of these con-
ditions in the general population without a previous family history of the disease. 
One such conditions is Huntington’s disease (HD; see Figure 1).
 
Figure 1. Information about Huntington’s Disease
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Availability of health-related genetic information to blood relatives
Genetic conditions and susceptibilities differ from other diseases and health-re-
lated risks because genetic information is shared among blood relatives. For ex-
ample, knowing an individual’s smoking status is not informative with regards to 
the health of his or her relatives. By contrast, anything one individual might learn 
about their personal genetic health risks indicates possible risks for family mem-
bers, proportionate to the degree of genetic relatedness (e.g. 100% for identical 
twins; 50% for parents, children, or siblings; 25% for first-degree cousins, aunts 
and uncles, grand-parents, or half-siblings). This is particularly true for disorders 
with relatively simple genetic inheritance patterns, like HD (see Figure 1).
In the absence of effective treatments, individuals may find such information 
either useful or harmful. For example, when considering pre-symptomatic testing 
for HD, some feel that having a result is important for family planning decisions, 
while others are concerned about the physical and psychological impact of having 
such test results (Evers-Kiebooms et al., 2002; van der Steenstraten, Tibben, Roos, 
van de Kamp, & Niermeijer, 1994). This presents an ethical and legal dilemma re-
garding whether such information should be disclosed to family members and by 
whom. 
For individuals this is not currently a legal dilemma, but an ethical one, since 
there is no law forbidding or forcing individuals to disclose genetic test results to 
their relatives. However, for medical organizations, the situation is becoming in-
creasingly complicated in this genomic era. Oaths of conduct and ethics are tak-
en by healthcare professionals all over the world (Crawshaw, 1994; Green, 2017; 
Hulkower, 2016), many of which are based on the Hippocratic oath of the 3rd cen-
tury CE (Loudon, 1994). The following statements are included in the modern Hip-
pocratic oath: 
“I will respect the privacy of my patients, for their problems are not disclosed 
to me that the world may know,” and “I will prevent disease whenever I can, for 
prevention is preferable to cure.”
These two obligations may be difficult to reconcile in the context of genetic 
information. Consider this example. A woman undergoes a genetic test, which un-
covers a BRCA1 gene mutation, which is known to significantly increase the risk 
of developing breast and ovarian cancer. She opts to undergo a prophylactic double 
mastectomy surgery and the removal of her ovaries to reduce her risk of develop-
ing cancer (Hartmann et al., 2001). The BRCA1 gene is not routinely screened for 
during healthcare evaluations, but is tested for by women with a known family risk 
or specific tumor histologies. Therefore, information about the mutation could be 
important for the woman’s sister, who, as a first degree relative, has a 50% risk of 
carrying the same mutation.
The woman does not want to disclose the result of her test to her sister. Should 
the woman’s doctor/medical provider respect her confidentiality, in line with the 
“respect privacy” part of the Hippocratic oath? Or does the provider have an ethical 
and/or legal obligation to inform the sister, in line with the “prevent disease” aspect 
of the oath? In other words, should the woman’s confidentiality take precedence 
over the health risk to the sister, or the other way around?  
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These questions are no longer hypothetical and have already reached the 
courts. For example, a case of non-disclosure of HD is currently being decided in 
the UK courts (ABC v St George’s Healthcare NHS Foundation Trust [2017] EWCA 
Civ 336’, 2017). In this case, action has been brought against the UK National 
Health Service (NHS) by a patient on the basis that the NHS owed a duty of care 
to disclose her father’s HD diagnosis to her. The daughter asserts that, had she 
been informed of the risk, and her own diagnosis was confirmed, she would have 
terminated her pregnancy. The High Court struck her claim on the grounds that 
there was no reasonably arguable duty of care owed to the daughter by the NHS. 
The decision of the High Court was appealed by the daughter, and the Court of 
Appeal reversed the High Court’s decision, remitting the case for trial. The dif-
fering decisions of the UK courts reflect the complexity of the moral, ethical, and 
legal issues in such cases.
The increasing use of genetics in medicine, coupled with the relatedness be-
tween family members, means that the concepts of medical ethics, consent, and 
confidentiality need to be revisited. Any such re-evaluation of established social 
norms should include broad and thorough public discussion. This is especially im-
portant when revisions of the social norms could fundamentally change how we 
conceptualize the “self.”
Many ethical and moral dilemmas are difficult to resolve because people hold 
strong and polarized views on them. These include the issues of abortion, capi-
tal punishment, gun ownership, and the age of consent, for which laws also differ 
across legal systems. Societies now face an additional dilemma: whether or not to 
disclosue genetic information to family members. People’s views on this issue have 
not been adequately explored.
The present study investigates public opinions about who should have a right 
to genetic information, and whether this information can be disclosed to relatives 
without the consent of the person to whom that information relates. In particular, 
we explore people’s views on two questions:
1. Do people have a moral obligation to share their genetic data with family 
members?
2. Should healthcare providers have a legal obligation to share such data when 
consent is withheld?
Objectives
The main aim of our study was to establish whether there is a relative consensus re-
garding the disclosure of genetic information to family members, or whether opin-
ions relating to this issue are polarized in society. This information is important for 
updating regulations and developing guidelines for the use of genetic data.
Method
Participants
Data were collected from individuals attending a public science engagement event 
run by The Accessible Genetics Consortium (www.tagc.world) at a university in 
London in 2018. The event was part of the Genes & Tonic series, which is dedicated 
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to promoting genetic knowledge and its application to different areas, such as edu-
cation, medicine, and justice. The event was advertised to the public through social 
media, websites of the university and partner organizations, posters, and word of 
mouth.
During the event, participants heard talks by a geneticist, a lawyer, and a ge-
netic counsellor, and engaged in activities during which data were collected. Re-
freshments were provided twice during the event. Data were recorded for 35 par-
ticipants (22 female) of a median age of 31.88 (SD =14.1, range 18 to 80). Fourteen 
participants had only secondary school education, 10 had completed undergradu-
ate university degrees, and 11 had completed postgraduate studies. 
All participants provided written consent for the use of their data in this re-
search. The research was approved by the Goldsmiths University Psychology De-
partment Ethics Committee.
Measures and Procedure 
Upon arrival, participants were provided with a welcome packet and a unique iden-
tifier number. This packet contained forms for participants to provide responses to 
specific questions asked throughout the event, as well as questions to capture de-
mographic information: age, sex, occupation, and highest education level achieved. 
Throughout the event, participants were provided with details drawn from the 
above-mentioned court case (ABC v St George’s Healthcare NHS Foundation Trust 
[2017] EWCA Civ 336’, 2017) concerning HD. 
Participants were asked to give their opinions three times during the event, as 
progressively more details about the case, as well as other information, were re-
leased to them in successive waves. 
At the outset of the evening, participants were provided with background in-
formation about the symptoms, progression, and prognosis for HD, and current 
treatment options. They were also presented with the following overview of the 
case notes (people’s names were altered for the event):
t )BWJOH TIPU BOE LJMMFEIJTXJGF BNBO 	'SFE
XBT TFOUFODFE UP B
hospital order and a restiction order (related to mental illness). In this con-
nection, his adult children attended family therapy at the same hospital.
t +BOVBSZ'SFETEPDUPSTGJSTUTVTQFDUFEUIBUIFNJHIUIBWF)%5IFZ
urged him to tell his family; he informed his brother but refused to tell his 
three daughters.
t BEJBHOPTJTPG)%XBTDPOGJSNFEUISPVHIHFOFUJDUFTUJOH
t %FDFNCFSo+BOVBSZ)FBMUIDBSFQSPGFTTJPOBMTSFQFBUFEMZVSHFE
Fred to disclose his diagnosis to his daughters. Fred withheld consent. 
t 0OFPGIJTEBVHIUFST	$MBJSF
XBTBDDJEFOUBMMZUPMECZ'SFET
doctor that her father was diagnosed with HD. 
t -BUF$MBJSFCFHBOUIFQSPDFTTPGTVJOHUIF/)4GPSOPUQSPWJEJOHUIJT
information officially at the time of diagnosis.
Participants at the event were also advised of the familial risk to Claire and her 
sisters, i.e. that they each had a 50% risk of developing HD. The fact that HD can 
impair cognitive function, and that this might have had an impact on the father’s 
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ability to understand his and his family’s situation, was not emphasized to the par-
ticipants, although some did comment on this in their feedback. Participants were 
then asked to give their opinions on a 7-point scale (1=not at all to 7=definitely) on 
the following three statements:
1) The patient (daughter) had a right to know about her father’s diagnosis.
2)  The National Health Service (NHS) should have been legally obliged to 
provide this information to the daughters.
3) The father had a moral responsibility to provide this information.
Participants were also invited to provide written feedback and comments dur-
ing each wave of data collection. 
The second wave of data collection was preceded by the additional information 
that the daughter (Claire) was pregnant at the time her father’s diagnosis was con-
firmed. The participants were also informed that she attested that, if she had known 
of her father’s diagnosis, she would have terminated her pregnancy, given her own 
risk of developing HD and the risk to her unborn child. The participants’ opinions 
were collected again as described above. 
The third wave of data collection was preceded by additional information. This 
time participants were given a hypothetical scenario that a cure for HD had been 
discovered, but was only effective if begun before symptoms appeared. In this sce-
nario, genetic testing for HD by the NHS was still only available to patients exhibit-
ing symptoms, or to those with a known family history of the disorder. As such, the 
daughter would only have been able to access the cure if she knew about her father’s 
diagnosis. The participants’ opinions were collected for the third time as described 
previously. It was made clear to them that the scenario was hypothetical (no cure 
for HD currently exists), but that this is an active area of research. 
Participants were asked to record their unique ID on each form they submit-
ted during the evening. Unfortunately, not all participants provided their unique 
ID on each form they submitted, which led to missing data on some aspects of the 
analyses (those involving all three waves).
Participants were also asked whether they had ever had a genetic test, if they 
knew anyone with a genetic condition, or if they had such a condition themselves. 
They were also asked how influential religion was in informing their opinions and 
decisions (not at all, somewhat, or greatly influenced) and how confident they were 
in their genetic knowledge on a scale of 0 (none) to 100 (entirely confident).  
Results
The average participant’s confidence in genetic knowledge was relatively low: 36.91 
(SD=26.27; range 0 to 85). Regarding the influence of religion on their opinions, 31 
participants (88.6%) reported not being influenced at all; three participants (8.6%) 
reported being influenced to some extent; and one participant (2.9%) reported 
strong influence. 
As can be seen in Figure 2, there was a general consensus that the father had a 
moral obligation to provide information to his daughter about his diagnosis. How-
ever, opinions were more divided when it came to the daughter’s right to such in-
formation. Participants’ responses were even more polarized when they were asked 
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whether the NHS should be legally obliged to disclose genetic information when 
consent has been withheld. Even following the final wave of information, when 
participants had been advised that the daughter was pregnant, and that, hypotheti-
cally, there was a cure for HD, 22% of participants still felt that there should be no 
legal obligation placed on the NHS to disclose the father’s diagnosis to the daughter.
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Figure 2. Summed percentage (across the 3 waves) of participants’ responses to the 3  
statements. Note: Percentage of responses (rather than participant numbers) are reported
As can be seen in Figure 3, participants’ opinions remained relatively stable 
throughout the questioning, with only small increases for each statement across the 
three waves of data collection.
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To Tell or Not to Tell…  75
Some potential group differences emerged, although the sample was under-
powered to test these statistically. Men tended to be more inclined toward mandat-
ing disclosure of the genetic information than women, particularly for the first two 
questions (Figure 4). Participants who had a genetic condition, either themselves 
or in their family, were also more inclined towards disclosure (Figure 5). As only 
four participants (11.5% of the sample) stated that their opinions were influenced 
by religion to some degree, group analyses of religion are not presented.
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Figure 4. Average score on a scale of 1–7 for men (N = 9) and women (N = 13) 
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Figure 5. Average score on a scale of 1–7 for participants without (N = 17)  
and with (N = 5) a genetic condition, either themselves or in the family.
Qualitative analysis 
The unscripted responses provided by participants clearly demonstrate their strong 
and polarized views. For example, when in favor of a patient’s privacy, participants 
made such statements as: “If your DNA isn’t your own, what is?”; “It remains Fred’s 
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right alone. Regardless of consequences.”; “The NHS were refused permission by 
the father, a violation of this goes against doctor-patient confidentiality.” When in 
favor of disclosure of the information to the relatives, participants said, for exam-
ple: “Any information to do with genetics like this must be shared.”; “Families need 
careful genetic counselling to deal with Huntington’s. It leads to early death there-
fore families need to know because of their children.” “Fred is now responsible for 
2 lives, so is under a lot of moral obligation. It’s the woman’s choice if she wants to 
terminate, not Fred. #Prochoice.” The full collection of responses is available from 
the authors upon request.
Conclusion
The results of this study demonstrate that people hold strong and polarized views 
on the issue of confidentiality, and the moral and legal duty to disclose genetic in-
formation to family members. In particular, participants disagreed about the legal 
obligations on healthcare providers to disclose a person’s genetic information to 
relatives, even when withholding information could have adverse impacts on the 
health, wellbeing, and life choices of those relatives.
Although the study sample size was small, it captured a wide range of ages, 
professions, and educational backgrounds. Conversely, the sample was also homo-
geneous in that all participants were interested in genetics, and had intentionally 
attended a genetic science engagement event. Over half the participants were stu-
dents, and 60% had completed degree-level studies, indicating high levels of educa-
tional attainment within the sample. The fact that such a diversity of views is pres-
ent within this sample suggests that the issue of privacy and disclosure of genetic 
information is complex and divisive.
The results also showed that exposure to the same information, including ex-
pert talks on genetics, law, and genetic counselling, did not lead to significantly 
increased similarity in participants’ views. A bigger and more representative study 
is needed to further explore demographic and other factors that may influence peo-
ple’s views on these matters. For example, the results indicated that having a genetic 
condition in the family may lead to viewing disclosure of genetic information to 
family members more favorably. 
The case presented in this study is relatively simple, as there is a single known 
genetic cause for HD. As discussed in the introduction, most diseases have much 
more complex etiologies, with a mixture of genetic and environmental factors 
potentially contributing. This etiological complexity makes risk estimates much 
harder, since genetic information is highly probabilistic. With this increased uncer-
tainty, deciding on ethical and legal responsibility becomes even more complicated. 
Nevertheless, the need for clarity on these matters is urgent. 
However, research shows that societies are unprepared for making informed 
decisions on updates to laws and policies. For example, a recent study revealed 
poor genetic literacy among the public when people were presented with multiple-
choice questions about simple genetic concepts (Chapman et al., 2018). A lack of 
knowledge, combined with strong polarized opinions, is a worrying position for 
society to be in. The present research highlights the need for improved genetic 
education, but also suggests that simply knowing the facts will not resolve the di-
To Tell or Not to Tell…  77
lemmas in this area. Further research is needed into the reasons for the strong 
polarized opinions as a step toward finding optimal solutions. Public engagement 
will be fundamental to these endeavors.
Limitations
The data presented here only represent the views of a small number of participants 
who were already engaged enough with genetics and genomics to attend the event. 
The numbers were insufficient to allow for meaningful inferential analyses, and 
this should be addressed in future studies. However, the findings that opinions are 
polarized and somewhat stable certainly does warrant further investigation. 
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